SLIT1 antibody is a research tool designed to detect SLIT1. a secreted glycoprotein belonging to the SLIT family of axon guidance ligands. SLIT1 plays a critical role in neural development, particularly in guiding axon pathfinding and neuronal migration by interacting with Roundabout (ROBO) receptors. It is predominantly expressed in the central nervous system, including the spinal cord, retina, and specific brain regions like the hypothalamus and olfactory bulb. Dysregulation of SLIT1 signaling has been linked to neurodevelopmental disorders, neurodegenerative diseases, and cancer metastasis.
SLIT1 antibodies are commonly used in techniques such as Western blotting, immunohistochemistry (IHC), and immunofluorescence (IF) to study protein expression, localization, and function. These antibodies are typically raised in hosts like rabbits or mice, with monoclonal variants offering high specificity and polyclonal versions providing broader epitope recognition. Validation often includes knockout controls or peptide blocking assays to confirm target specificity.
Research applications focus on understanding SLIT1’s role in neural circuit formation, synaptic plasticity, and its potential as a biomarker in diseases like glioblastoma or Alzheimer’s. Recent studies also explore its dual role as both a chemoattractant and chemorepellent in cellular contexts. Commercial SLIT1 antibodies vary in reactivity across species (human, mouse, rat), and selecting appropriate clones requires consideration of experimental models and validation data.